Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
Attending:	O
___.	O
Chief	O
Complaint:	O
STEMI/	O
Chest	O
Pain	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
cardiac	O
catheterization	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
female	O
with	O
history	O
of	O
DM,	O
afib,	O
CAD	O
s/p	O
CABG	O
with	O
LIMA	O
to	O
LAD,	O
SVG	O
to	O
RCA	O
and	O
OM	O
who	O
presented	O
to	O
___	O
with	O
chest	O
pain	O
that	O
started	O
at	O
around	O
2pm	O
while	O
she	O
was	O
watching	O
TV.	O
Pt	O
reports	O
a	O
pressure	O
like	O
pain	O
across	O
her	O
anterior	O
chest	O
with	O
radiation	O
down	O
both	O
arms	O
and	O
pain	O
in	O
back.	O
She	O
notes	O
associated	O
diaphoresis	O
and	O
malaise	O
but	O
denies	O
associated	O
palpitations	O
or	O
nausea.	O
She	O
took	O
nitroglycerin	O
as	O
well	O
as	O
81	O
mg	O
ASA	O
at	O
home	O
with	O
no	O
relief	O
and	O
then	O
called	O
___.	O
At	O
___	O
ekg	O
was	O
concerning	O
for	O
inferior	O
STEMI.	O
She	O
was	O
started	O
on	O
a	O
Heparin	O
gtt,	O
given	O
300mg	O
Plavix	O
and	O
325mg	O
ASA	O
and	O
transferred	O
to	O
___	O
for	O
further	O
management.	O
Cardiac	O
catheterization	O
showed	O
3	O
vessel	O
CAD	O
with	O
patent	O
SVG	O
to	O
OM	O
and	O
LIMA	O
to	O
LAD	O
as	O
well	O
as	O
occlusion	O
of	O
SVG	O
to	O
RCA.	O
Pt	O
underwent	O
placement	O
of	O
DES	O
to	O
the	O
in	O
the	O
mid	O
RCA.	O
She	O
was	O
loaded	O
with	O
plavix	O
300	O
mg	O
x	O
2	O
and	O
transferred	O
to	O
the	O
CCU.	O
On	O
arrival	O
to	O
the	O
CCU	O
patient	O
denied	O
any	O
further	O
chest	O
pain	O
or	O
shortness	O
of	O
breath.	O
.	O
The	O
patient	O
notes	O
increasing	O
chest	O
pressure	O
over	O
the	O
past	O
month	O
that	O
has	O
been	O
responsive	O
to	O
NGT.	O
She	O
has	O
significant	O
shortness	O
of	O
breath	O
at	O
baseline	O
and	O
states	O
that	O
she	O
cannot	O
walk	O
from	O
one	O
room	O
to	O
another	O
in	O
her	O
home	O
without	O
becoming	O
short	O
of	O
breath.	O
She	O
also	O
notes	O
3	O
pillow	O
orthopnea	O
as	O
well	O
as	O
peripheral	O
edema	O
at	O
baseline	O
but	O
denies	O
PND.	O
.	O
She	O
reports	O
a	O
1	O
month	O
history	O
of	O
cough	O
productive	O
of	O
clear	O
sputum	O
but	O
denies	O
associated	O
fevers	O
or	O
chills,	O
hemoptysis,	O
blood	B-Lower_gastrointestinal_haemorrhage
in	B-Lower_gastrointestinal_haemorrhage
stools,	B-Lower_gastrointestinal_haemorrhage
urinary	O
frequency	O
or	O
urgency,	O
history	O
of	O
stroke,	O
or	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed.	B-Upper_gastrointestinal_haemorrhage
All	O
of	O
the	O
other	O
review	O
of	O
systems	O
were	O
negative.	O
Past	O
Medical	O
History:	O
1.	O
CARDIAC	O
RISK	O
FACTORS:	O
Diabetes,	O
Hypertension	O
2.	O
CARDIAC	O
HISTORY:	O
-	O
CABG:	O
LIMA	O
to	O
the	O
LAD,	O
SVG	O
to	O
the	O
RCA	O
and	O
OM	O
___	O
years	O
ago	O
3.	O
OTHER	O
PAST	O
MEDICAL	O
HISTORY:	O
-	O
Diabetes	O
Mellitus,	O
non	O
insulin	O
dependent	O
-	O
PVD	O
s/p	O
R	O
fem-pop	O
bypass	O
and	O
R	O
toe	O
amputation	O
-	O
COPD,	O
no	O
home	O
oxygen	O
requirement	O
-	O
HTN	O
-	O
Hypothyrodism	O
-	O
Atrial	O
Fibrillation	O
(on	O
warfarin	O
in	O
the	O
past)	O
now	O
on	O
amiodarone	O
Social	O
History:	O
___	O
Family	O
History:	O
-	O
No	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death;	O
otherwise	O
non-contributory.	O
-	O
Mother:	O
-	O
Father:	O
died	O
of	O
lung	O
cancer	O
Physical	O
Exam:	O
ADMISSION	O
EXAM	O
PHYSICAL	O
EXAMINATION:	O
VS:	O
T=96.9	O
/	O
BP=	O
170/54	O
/	O
HR=	O
61	O
/	O
RR=14	O
O2	O
sat=	O
96%	O
on	O
3L	O
NC	O
GENERAL:	O
NAD.	O
Oriented	B-Delirium
x3.	B-Delirium
Mood,	O
affect	O
appropriate.	O
Lying	O
flat	O
in	O
no	O
acute	O
distress	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
were	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthalesma.	O
NECK:	O
Supple	O
with	O
JVP	O
to	O
the	O
earlobe.	O
Mildy	O
enlarged	O
thyroid	O
CARDIAC:	O
Median	O
sternotomy	O
well	O
healed	O
PMI	O
located	O
in	O
___	O
intercostal	O
space,	O
midclavicular	O
line.	O
RR,	O
faint	O
S1,	O
S2.	O
___	O
blowing	O
holosystolic	O
murmur	O
heard	O
best	O
at	O
RLSB.	O
No	O
thrills,	O
lifts.	O
No	O
S3	O
or	O
S4.	O
LUNGS:	O
No	O
chest	O
wall	O
deformities,	O
scoliosis	O
or	O
kyphosis.	O
Resp	O
were	O
unlabored,	O
no	O
accessory	O
muscle	O
use.	O
CTAB,	O
no	O
crackles,	O
wheezes	O
or	O
rhonchi	O
anteriorly	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
HSM	O
or	O
tenderness.	O
Abd	O
aorta	O
not	O
enlarged	O
by	O
palpation.	O
EXTREMITIES:1+	O
pitting	O
edema	O
to	O
the	O
level	O
of	O
the	O
mid	O
shin	O
bilaterally	O
R	O
>	O
L	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	O
scars,	O
or	O
xanthomas.	O
PULSES:	O
Right:	O
Carotid	O
2+	O
Femoral	O
2+	O
DP,	O
___	O
Dopplerable	O
Left:	O
Carotid	O
2+	O
Femoral	O
2+	O
DP,	O
___	O
Dopplerable	O
Neuro:	O
CN	O
II-XII	O
intact	O
grossly,	O
moving	O
all	O
extremities	O
well,	O
sensation	O
in	O
tact	O
throughout	O
Pertinent	O
Results:	O
Laboratory	O
Data	O
From	O
___	O
___	O
at	O
1800:	O
WBC	O
8.7	O
HCT	O
23.1	O
HgB	O
7.4	O
Plt	O
420	O
___	O
13.9/1.10	O
PTT	O
31.4	O
NA	O
132	O
K	O
4.7	O
Cl	O
98	O
CO2	O
22	O
BUN	O
38	O
Cr	O
2.3	O
Glucose	O
159	O
Ca	O
8.8	O
LDH	O
182	O
CK	O
36	O
.	O
Labs	O
on	O
Transfer:	O
___	O
03:55AM	O
BLOOD	O
WBC-9.6	O
RBC-2.99*	O
Hgb-7.0*	O
Hct-22.9*	O
MCV-77*	O
MCH-23.5*	O
MCHC-30.7*	O
RDW-16.4*	O
Plt	O
___	O
___	O
03:55AM	O
BLOOD	O
Glucose-192*	O
UreaN-37*	O
Creat-2.1*	O
Na-131*	O
K-5.0	O
Cl-97	O
HCO3-25	O
AnGap-14	O
___	O
03:55AM	O
BLOOD	O
ALT-17	O
AST-34	O
LD(LDH)-203	O
CK(CPK)-246*	O
AlkPhos-99	O
TotBili-0.3	O
___	O
03:55AM	O
BLOOD	O
Albumin-3.5	O
Calcium-8.4	O
Phos-4.6*	O
Mg-2.2	O
Iron-16*	O
.	O
Pertinent	O
Labs:	O
.	O
Iron	O
studies	O
___	O
03:55AM:	O
BLOOD	O
calTIBC-416	O
Ferritn-20	O
TRF-320	O
.	O
A1c	O
___	O
07:33AM:	O
%HbA1c-6.4*	O
eAG-137*	O
.	O
Lipid	O
Panel	O
___	O
07:20AM:	O
Triglyc-78	O
HDL-59	O
CHOL/HD-2.4	O
LDLcalc-67	O
Cardiac	O
Enzymes:	O
___	O
10:30PM	O
BLOOD	O
CK-MB-18*	O
MB	O
Indx-11.8*	O
cTropnT-0.73*	O
___	O
03:55AM	O
BLOOD	O
CK-MB-33*	O
MB	O
Indx-13.4*	O
cTropnT-0.94*	O
___	O
04:04PM	O
BLOOD	O
CK-MB-46*	O
MB	O
Indx-13.1*	O
cTropnT-1.24*	O
___	O
11:05PM	O
BLOOD	O
CK-MB-32*	O
MB	O
Indx-12.2*	O
cTropnT-1.10*	O
.	O
Labs	O
on	O
Discharge:	O
___	O
06:20AM	O
BLOOD	O
WBC-9.2	O
RBC-3.61*	O
Hgb-9.2*	O
Hct-28.7*	O
MCV-80*	O
MCH-25.5*	O
MCHC-32.1	O
RDW-16.9*	O
Plt	O
___	O
___	O
06:20AM	O
BLOOD	O
Glucose-120*	O
UreaN-32*	O
Creat-2.0*	O
Na-135	O
K-4.7	O
Cl-98	O
HCO3-28	O
AnGap-14	O
.	O
Pertinent	O
Studies	O
-	O
ECG	O
(___):	O
Most	O
prominent	O
are	O
ST	O
elevations	O
in	O
II,	O
III,	O
and	O
AVF.	O
Question	O
biatrial	O
enlargment	O
post	O
prominent	O
in	O
RA,	O
NSR,	O
normal	O
intervals.	O
.	O
-	O
ECHO	O
(___):	O
The	O
left	O
atrium	O
is	O
elongated.	O
Left	O
ventricular	O
wall	O
thicknesses	O
and	O
cavity	O
size	O
are	O
normal.	O
There	O
is	O
mild	O
regional	O
left	O
ventricular	O
systolic	O
dysfunction	O
with	O
focal	O
hypokinesis	O
of	O
the	O
distal	O
inferior	O
wall.	O
The	O
remaining	O
segments	O
contract	O
normally	O
(LVEF	O
=	O
55-60	O
%).	O
The	O
estimated	O
cardiac	O
index	O
is	O
normal	O
(>=2.5L/min/m2).	O
Tissue	O
Doppler	O
imaging	O
suggests	O
an	O
increased	O
left	O
ventricular	O
filling	O
pressure	O
(PCWP>18mmHg).	O
Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal.	O
The	O
diameters	O
of	O
aorta	O
at	O
the	O
sinus,	O
ascending	O
and	O
arch	O
levels	O
are	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(3)	O
are	O
mildly	O
thickened	O
but	O
aortic	O
stenosis	O
is	O
not	O
present.	O
No	O
aortic	O
regurgitation	O
is	O
seen.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
mitral	O
valve	O
prolapse.	O
There	O
is	O
mild-moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
There	O
is	O
an	O
anterior	O
space	O
which	O
most	O
likely	O
represents	O
a	O
prominent	O
fat	O
pad.	O
IMPRESSION:	O
Normal	O
left	O
ventricular	O
cavity	O
size	O
with	O
mild	O
regional	O
systolic	O
dysfunction	O
c/w	O
CAD.	O
Mild-moderate	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
.	O
-	O
CARDIAC	O
CATH	O
(___):	O
Findings:	O
LMCA:	O
Open	O
LAD:	O
60%	O
___	O
/	O
60-70%	O
mid	O
prior	O
to	O
LIMA	O
LCX:	O
90%	O
___	O
/	O
OM	O
occlusion	O
RCA:	O
90%	O
mid	O
/	O
Diffuse	O
distal	O
SVG:	O
1)	O
OM	O
Patent	O
2)	O
RCA	O
occluded	O
LIMA:	O
LAD	O
patent	O
Intervention:	O
Intervention	O
with	O
DES	O
to	O
mid	O
Native	O
RCA	O
with	O
0%	O
residual.	O
Assessment:	O
3	O
vessel	O
CAD	O
with	O
patent	O
SVG	O
to	O
OM	O
and	O
LIMA	O
to	O
LAD	O
Occlusion	O
of	O
SVG	O
to	O
RCA	O
as	O
culprit	O
for	O
STEMI	O
Successful	O
DES	O
to	O
native	O
RCA	O
ASA	O
81mg	O
daily	O
and	O
Plavix	O
75mg	O
daily	O
Brief	O
Hospital	O
Course:	O
Primary	O
Reason	O
for	O
Hospitalization:	O
___	O
yo	O
female	O
with	O
history	O
of	O
CAD	O
s/p	O
CABG,	O
DM,	O
HTN	O
p/w	O
STEMI	O
with	O
thrombosis	O
of	O
SVG	O
to	O
RCA	O
now	O
s/p	O
placement	O
of	O
DES	O
to	O
the	O
RCA.	O
.	O
Active	O
Issues:	O
#	O
STEMI:	O
Patient	O
was	O
transferred	O
to	O
___	O
from	O
___	O
where	O
she	O
had	O
presented	O
with	O
chest	O
pain	O
with	O
EKG	O
concerning	O
for	O
interior	O
STEMI.	O
She	O
was	O
started	O
on	O
a	O
heparin	O
drip,	O
plavix	O
loaded	O
and	O
underwent	O
cardiac	O
catheterization	O
which	O
showed	O
3-vessel	O
disease	O
and	O
thrombosis	O
of	O
her	O
SVG	O
to	O
the	O
RCA.	O
Her	O
LIMA	O
graph	O
and	O
SVG	O
to	O
OM	O
were	O
patent.	O
She	O
underwent	O
placement	O
of	O
one	O
DES	O
to	O
her	O
native	O
RCA	O
with	O
restoration	O
of	O
flow.	O
The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
with	O
impovement	O
in	O
ST	O
elevations	O
on	O
her	O
EKG.	O
Troponin	O
and	O
CK	O
were	O
noted	O
to	O
peak	O
at	O
1.24	O
and	O
350	O
(CK-MB	O
46)	O
and	O
then	O
trend	O
downward.	O
She	O
initally	O
had	O
___	O
residual	O
chest	O
pain	O
after	O
the	O
cath	O
which	O
resolved	O
the	O
following	O
morning.	O
She	O
remained	O
chest	O
pain	O
free	O
for	O
the	O
remainder	O
of	O
the	O
admission.	O
She	O
should	O
continue	O
taking	O
plavix	O
75mg	O
PO	O
daily	O
for	O
at	O
least	O
one	O
year	O
and	O
aspirin	O
325mg	O
daily	O
indefinitely.	O
She	O
was	O
also	O
started	O
on	O
atorvastatin	O
80mg	O
daily.	O
.	O
#	O
Acute	O
on	O
Chronic	O
diastolic	O
CHF:	O
Pt	O
reports	O
history	O
of	O
CHF	O
requiring	O
home	O
lasix.	O
She	O
was	O
clinically	O
volume	O
overloaded	O
on	O
exam,	O
with	O
elevated	O
JVP	O
and	O
crackles	O
on	O
lung	O
exam	O
and	O
had	O
a	O
chest	O
xray	O
showing	O
pulmonary	O
edema.	O
She	O
received	O
gentle	O
hydration	O
post	O
catheterization	O
for	O
renal	O
protection	O
in	O
addition	O
to	O
2	O
units	O
of	O
PRBCs	O
for	O
anemia	O
as	O
described	O
below.	O
She	O
was	O
then	O
diuresed	O
with	O
bolus	O
doses	O
of	O
20	O
mg	O
IV	O
lasix	O
with	O
good	O
response.	O
Echo	O
on	O
HD	O
1	O
showed	O
normal	O
left	O
ventricular	O
cavity	O
size	O
with	O
mild	O
regional	O
systolic	O
dysfunction	O
with	O
hypokinesis	O
of	O
the	O
inferior	O
wall	O
and	O
preserved	O
LVEF	O
of	O
55-60%.	O
She	O
appeared	O
clinically	O
euvolemic	O
at	O
the	O
time	O
of	O
discharge.	O
.	O
#	O
Sinus	O
Bradycardia-	O
At	O
the	O
time	O
of	O
admission	O
the	O
patient	O
was	O
noted	O
to	O
be	O
in	O
sinus	O
bradycardia	O
with	O
heart	O
rates	O
in	O
the	O
low	O
to	O
mid	O
___.	O
Given	O
her	O
recent	O
MI	O
there	O
was	O
some	O
concern	O
for	O
involvement	O
of	O
her	O
conduction	O
system.	O
Her	O
beta	O
blocker	O
was	O
initially	O
held	O
however	O
she	O
was	O
restarted	O
on	O
a	O
decreased	O
does	O
of	O
PO	O
metoprolol	O
(25	O
mg	O
BID	O
from	O
50	O
mg	O
TID	O
at	O
home)	O
and	O
maintained	O
heart	O
rates	O
of	O
55-60.	O
.	O
#	O
Hx	O
Atrial	O
Fibrillation:	O
Pt	O
has	O
history	O
of	O
afib	O
previously	O
on	O
coumadin	O
which	O
was	O
stopped	O
a	O
year	O
ago	O
for	O
unknown	O
reasons.	O
The	O
patient	O
remained	O
in	O
sinus	O
rhythm	O
throughout	O
her	O
hospitalization	O
and	O
was	O
continued	O
on	O
her	O
home	O
amiodarone.	O
Electrolytes	O
were	O
repleted	O
as	O
needed.	O
Her	O
beta	O
blocker	O
was	O
initially	O
held	O
in	O
the	O
setting	O
of	O
bradycardia	O
but	O
was	O
restarted	O
at	O
a	O
reduced	O
dose	O
on	O
HD	O
1	O
as	O
stated	O
above.	O
.	O
#	O
Microcytic	O
anemia:	O
Pt	O
was	O
anemic	O
on	O
admission	O
with	O
a	O
Hct	O
of	O
23.1.	O
Iron	O
studies	O
were	O
consistent	O
with	O
iron	O
deficieny	O
anemia	O
with	O
a	O
low	O
iron,	O
low	O
normal	O
ferritin	O
and	O
high	O
normal	O
TIBC.	O
The	O
patinent	O
denied	O
any	O
clear	O
source	O
of	O
bleeding	O
including	O
bright	O
red	O
blood	O
per	O
rectum,	O
melena	O
or	O
hemoptysis.	O
She	O
was	O
transfused	O
2	O
units	O
of	O
PRBCs	O
with	O
appropriate	O
response	O
in	O
her	O
HCT	O
and	O
HCT	O
remained	O
stable	O
throughout	O
the	O
rest	O
of	O
her	O
hospitalization.	O
She	O
should	O
start	O
iron	O
supplementation	O
and	O
have	O
an	O
outpatient	O
colonoscopy	B-Lower_gastrointestinal_haemorrhage
in	O
3	O
months	O
to	O
evaluate	O
for	O
possible	O
GI	B-Lower_gastrointestinal_haemorrhage
source	O
of	O
bleed.	B-Lower_gastrointestinal_haemorrhage
.	O
#	O
___	O
:	O
On	O
admission	O
the	O
pts	O
creatinine	O
noted	O
to	O
be	O
elevated	O
to	O
2.3.	O
Her	O
baseline	O
Cr	O
is	O
unknown	O
however	O
patient	O
is	O
not	O
aware	O
of	O
known	O
renal	O
dysfunction.	O
She	O
was	O
given	O
gental	O
IVF	O
for	O
renal	O
protection	O
in	O
the	O
post-cath	O
setting	O
in	O
addition	O
to	O
the	O
blood	O
transfusion	O
described	O
above.	O
Her	O
home	O
lisinopril	O
was	O
initally	O
held	O
in	O
the	O
setting	O
of	O
acute	O
kidney	O
injury.	O
Her	O
creatinine	O
remained	O
stable	O
over	O
the	O
course	O
of	O
her	O
hospitalization	O
and	O
was	O
2.0	O
at	O
the	O
time	O
of	O
discharge.	O
Her	O
lisinopril	O
and	O
potassium	O
supplements	O
were	O
discontinued.	O
She	O
should	O
have	O
repeat	O
labs	O
drawn	O
on	O
___	O
with	O
labs	O
sent	O
to	O
her	O
primary	O
care	O
provider	O
for	O
continued	O
monitoring	O
of	O
her	O
renal	O
function	O
and	O
to	O
determine	O
whether	O
she	O
can	O
restart	O
her	O
lisinopril.	O
.	O
Stable	O
Issues:	O
.	O
#	O
COPD:	O
Pt	O
with	O
history	O
of	O
COPD	O
not	O
on	O
home	O
oxygen	O
but	O
with	O
new	O
oxygen	O
requirement	O
on	O
admission,	O
thought	O
likely	O
___	O
pulmonary	O
edema	O
and	O
not	O
a	O
COPD	B-Lower_respiratory_tract_infection
exacerbation.	B-Lower_respiratory_tract_infection
She	O
was	O
diuresed	O
as	O
above	O
and	O
weaned	O
off	O
oxygen.	O
At	O
the	O
time	O
of	O
discharge	O
she	O
was	O
maintaining	O
good	O
oxygen	O
saturation	O
on	O
room	O
air.	O
.	O
#	O
DMII-	O
The	O
patients	O
home	O
glipizide	O
was	O
held	O
in	O
the	O
setting	O
of	O
elevated	O
creatinine.	O
Glucose	O
control	O
was	O
maintained	O
with	O
sliding	O
scale	O
insulin	O
throughout	O
her	O
admission.	O
.	O
#	O
Hypothyroidism:	O
She	O
was	O
continued	O
on	O
her	O
home	O
levothyroxine	O
dose	O
of	O
100mcg	O
PO	O
daily.	O
.	O
#	O
HTN-	O
Her	O
home	O
lisinopril	O
and	O
metoprolol	O
were	O
initially	O
held,	O
and	O
she	O
was	O
restarted	O
on	O
a	O
lower	O
dose	O
of	O
metoprolol	O
on	O
HD	O
as	O
above.	O
.	O
#Transitional	O
issues-	O
-	O
She	O
maintained	O
full	O
code	O
status	O
throughout	O
admission.	O
-	O
She	O
should	O
continue	O
plavix	O
75mg	O
daily	O
for	O
at	O
least	O
one	O
year	O
and	O
ASA	O
325mg	O
indefinitely.	O
-	O
She	O
was	O
started	O
on	O
high	O
dose	O
atorvastatin	O
(80mg	O
PO	O
daily).	O
-	O
Her	O
metoprolol	O
dose	O
was	O
decreased	O
from	O
50mg	O
TID	O
to	O
25mg	O
BID	O
due	O
to	O
sinus	O
bradycardia	O
(HR	O
___.	O
-	O
She	O
will	O
need	O
repeat	O
labs	O
next	O
week	O
to	O
monitor	O
renal	O
function	O
with	O
results	O
sent	O
to	O
her	O
PCP.	O
-	O
Lisinopril	O
and	O
potassium	O
supplements	O
were	O
discontinued	O
due	O
to	O
her	O
renal	O
failure.	O
She	O
should	O
follow	O
up	O
with	O
her	O
PCP	O
regarding	O
whether	O
to	O
resume	O
these	O
medications.	O
-	O
Patient	O
will	O
need	O
to	O
continue	O
iron	O
supplements	O
for	O
her	O
iron	O
deficiency	O
anemia	O
and	O
schedule	O
outpatient	O
colonoscopy	O
in	O
3	O
months.	O
Medications	O
on	O
Admission:	O
-	O
Lasix	O
20mg	O
PO	O
Qd	O
-	O
Glipizide	O
10mg	O
PO	O
Qd	O
-	O
Lisinopril	O
5mg	O
PO	O
Qd	O
-	O
Pantoprazole	O
40mg	O
Po	O
qd	O
-	O
KCL	O
20mEq	O
-	O
Amiodarone	O
200mg	O
PO	O
BID	O
-	O
Metoprolol	O
50mg	O
PO	O
TID	O
-	O
Levothyroxine	O
100mcg	O
Qd	O
-	O
Asa	O
81mg	O
PO	O
Qd	O
-	O
Nitro	O
SL	O
PRN	O
Discharge	O
Medications:	O
1.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
once	O
a	O
day.	O
2.	O
clopidogrel	O
75	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*11*	O
3.	O
aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
4.	O
pantoprazole	O
40	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
Q24H	O
(every	O
24	O
hours).	O
5.	O
furosemide	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
amiodarone	O
200	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
7.	O
metoprolol	O
tartrate	O
25	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
8.	O
levothyroxine	O
100	O
mcg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
9.	O
nitroglycerin	O
0.4	O
mg	O
Tablet,	O
Sublingual	O
Sig:	O
One	O
(1)	O
tablet	O
Sublingual	O
as	O
directed	O
as	O
needed	O
for	O
chest	O
pain.	O
Disp:*25	O
tablets*	O
Refills:*0*	O
10.	O
glipizide	O
5	O
mg	O
Tablet	O
Extended	O
Rel	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Extended	O
Rel	O
24	O
hr	O
PO	O
once	O
a	O
day.	O
Disp:*30	O
Tablet	O
Extended	O
Rel	O
24	O
hr(s)*	O
Refills:*2*	O
11.	O
atorvastatin	O
80	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Tablet(s)*	O
Refills:*2*	O
12.	O
neomycin-polymyxin-HC	O
3.5-10,000-1	O
mg-unit/mL-%	O
Drops,	O
Suspension	O
Sig:	O
Four	O
(4)	O
Drop	O
Otic	O
TID	O
(3	O
times	O
a	O
day)	O
for	O
6	O
days.	O
Disp:*1	O
bottle*	O
Refills:*0*	O
13.	O
ferrous	O
sulfate	O
325	O
mg	O
(65	O
mg	O
iron)	O
Capsule,	O
Extended	O
Release	O
Sig:	O
One	O
(1)	O
Capsule,	O
Extended	O
Release	O
PO	O
DAILY	O
(Daily).	O
Disp:*30	O
Capsule,	O
Extended	O
Release(s)*	O
Refills:*2*	O
14.	O
Outpatient	O
Lab	O
Work	O
Please	O
check	O
Chem-7	O
and	O
CBC	O
on	O
___	O
and	O
call	O
results	O
to	O
Dr.	O
___	O
at	O
Phone:	O
___	O
Fax:	O
___	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
ST	O
Elevation	O
Myocardial	O
Infarction	O
Hypertension	O
Acute	O
Kidney	O
injury	O
Acute	O
on	O
Chronic	O
Diastolic	O
Congestive	O
heart	O
failure	O
Atrial	O
fibrillation	O
Acute	O
blood	O
loss	O
anemia	O
Discharge	O
Condition:	O
Mental	B-Delirium
Status:	B-Delirium
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Out	B-Mobile_with_assistance
of	B-Mobile_with_assistance
Bed	B-Mobile_with_assistance
with	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
to	B-Mobile_with_assistance
chair	B-Mobile_with_assistance
or	O
wheelchair.	B-Mobile_with_aid
Discharge	O
Instructions:	O
You	O
had	O
a	O
heart	O
attack	O
and	O
needed	O
a	O
cardiac	O
catheterization.	O
this	O
showed	O
a	O
blockage	O
in	O
your	O
right	O
coronary	O
artery	O
that	O
was	O
opened	O
and	O
stented	O
with	O
a	O
drug	O
eluting	O
stent.	O
You	O
will	O
need	O
to	O
take	O
a	O
whole	O
adult	O
dose	O
of	O
aspirin	O
(325	O
mg)	O
and	O
clopidogrel	O
(Palvix)	O
every	O
day	O
for	O
at	O
least	O
one	O
year.	O
Do	O
not	O
stop	O
taking	O
this	O
medicine	O
or	O
miss	O
any	O
doses	O
unless	O
Dr.	O
___	O
you	O
it	O
is	O
OK.	O
You	O
risk	O
another	O
heart	O
attack	O
from	O
a	O
blocked	O
stent	O
if	O
you	O
stop	O
taking	O
these	O
medicines.	O
WE	O
also	O
started	O
you	O
on	O
new	O
medicines	O
to	O
help	O
your	O
heart	O
recover	O
from	O
the	O
heart	O
attack.	O
You	O
blood	O
count	O
was	O
low	O
when	O
you	O
were	O
admitted	O
and	O
you	O
needed	O
to	O
get	O
2	O
units	O
of	O
blood.	O
We	O
think	O
the	O
bleeding	B-Lower_gastrointestinal_haemorrhage
is	O
coming	O
from	O
your	O
abdomen	B-Lower_gastrointestinal_haemorrhage
and	O
you	O
will	O
need	O
to	O
get	O
a	O
colonoscopy	B-Lower_gastrointestinal_haemorrhage
in	O
a	O
few	O
months	O
to	O
check	O
for	O
signs	O
of	O
bleeding.	B-Lower_gastrointestinal_haemorrhage
Please	O
discuss	O
this	O
with	O
Dr.	O
___.	O
You	O
will	O
need	O
to	O
take	O
iron	O
supplements	O
until	O
then.	O
These	O
can	O
make	O
you	O
constipated	B-Constipation
so	O
take	O
a	O
stool	O
softener,	O
colace,	O
at	O
the	O
same	O
time.	O
You	O
had	O
extra	O
fluid	O
in	O
your	O
body	O
that	O
was	O
making	O
it	O
hard	O
for	O
you	O
to	O
breathe.	O
You	O
were	O
given	O
extra	O
lasix	O
and	O
your	O
home	O
dose	O
of	O
lasix	O
was	O
restarted.	O
You	O
need	O
to	O
watch	O
for	O
fluid	O
to	O
accumulate	O
again.	O
Weigh	O
yourself	O
every	O
morning	O
before	O
breakfast,	O
call	O
Dr.	O
___	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs	O
in	O
1	O
day	O
or	O
5	O
pounds	O
in	O
3	O
days.	O
Your	O
kidney	O
function	O
worsened	O
from	O
the	O
heart	O
attack	O
and	O
the	O
lasix,	O
you	O
will	O
need	O
to	O
have	O
blood	O
work	O
checked	O
on	O
___	O
to	O
make	O
sure	O
the	O
kidneys	O
are	O
recovering.	O
.	O
We	O
made	O
the	O
following	O
changes	O
to	O
your	O
medicines:	O
1.	O
Start	O
taking	O
clopidogrel	O
(Plavix)	O
to	O
keep	O
the	O
stent	O
open	O
and	O
prevent	O
another	O
heart	O
attack	O
2.	O
Increase	O
the	O
aspirin	O
dose	O
to	O
325	O
mg	O
daily	O
3.	O
Discontinue	O
the	O
lisinopril	O
for	O
now	O
until	O
your	O
kidney	O
function	O
normalizes	O
4.	O
Stop	O
potassium	O
pills	O
until	O
your	O
kidneys	O
recover	O
5.	O
Decrease	O
metoprolol	O
to	O
twice	O
daily	O
from	O
three	O
times	O
a	O
day	O
6.	O
STart	O
atorvastatin	O
(Lipitor)	O
to	O
lower	O
your	O
cholesterol	O
7.	O
STart	O
antibiotic	O
ear	O
drops	O
to	O
treat	O
the	O
pain	O
in	O
your	O
ear,	O
stop	O
using	O
these	O
after	O
6	O
days.	O
8.	O
Start	O
iron	O
supplements	O
daily	O
to	O
replete	O
your	O
iron	O
stores.	O
Followup	O
Instructions:	O
___	O

